Latest observed contract and full preserved history
Saved source observation · CN4171505
Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)
This is the latest observation of this contract, and the explorer’s totals use its value.
$317,718,916.90
Full reported contract value · AUD including applicable GST · 2025-07-01 to 2028-06-30
- Reporting agency
- National Blood Authority
- Reported supplier
- Roche Products Pty Ltd
- Reported ABN
- 70 000 132 865. Exemption as supplied: No.
- Category
- Drugs and Pharmaceutical Products
- Procurement method
- Limited tender
- Original publication
- 2025-07-18 16:07:00 (ACT local time as supplied)
- Amendment publication
- Original notice; no amendment publication supplied
- Amendment reason
- Not supplied
- Agency reference
- Not supplied
- Approach to market / standing offer
- ATM not supplied / Standing offer not supplied
- Consultancy
- No
- Confidentiality as reported
- Contract: Yes; outputs: No
- Source observation
- CN4171505 · Official weekly workbook ending 2025-07-19 · sheet “Contract Notice Export”, row 70.
Find this exact notice on AusTenderDownload attributed contract card
The original register may now show later corrections. The card and this observation keep the saved source date.